Literature DB >> 22767137

Identification of expanded alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) study.

Flora Tassone1, Nimrah S Choudhary, Federica Tassone, Blythe Durbin-Johnson, Robin Hansen, Irva Hertz-Picciotto, Isaac Pessah.   

Abstract

Fragile X syndrome (FXS) is a neuro-developmental disorder characterized by intellectual disabilities and autism spectrum disorders (ASD). Expansion of a CGG trinucleotide repeat (>200 repeats) in the 5'UTR of the fragile X mental retardation gene, is the single most prevalent cause of cognitive disabilities. Several screening studies for FXS, among individuals with ID from different ethnic populations, have indicated that the prevalence of the syndrome varies between 0.5 and 16 %. Because the high co-morbidity with autism, we have conducted a screening study of the cohort from CHARGE, a large-scale, population-based, case control study. We have identified six subjects carrying an expanded allele, which emphasize the importance of screening for FXS in a population with intellectual disabilities and ASD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22767137      PMCID: PMC4596818          DOI: 10.1007/s10803-012-1580-2

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  72 in total

1.  Heterozygous fragile X female: historical, physical, cognitive, and cytogenetic features.

Authors:  A Cronister; R Schreiner; M Wittenberger; K Amiri; K Harris; R J Hagerman
Journal:  Am J Med Genet       Date:  1991 Feb-Mar

2.  Fragile X genotype characterized by an unstable region of DNA.

Authors:  S Yu; M Pritchard; E Kremer; M Lynch; J Nancarrow; E Baker; K Holman; J C Mulley; S T Warren; D Schlessinger
Journal:  Science       Date:  1991-05-24       Impact factor: 47.728

3.  Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.

Authors:  A J Verkerk; M Pieretti; J S Sutcliffe; Y H Fu; D P Kuhl; A Pizzuti; O Reiner; S Richards; M F Victoria; F P Zhang
Journal:  Cell       Date:  1991-05-31       Impact factor: 41.582

4.  Conversational analyses of males with fragile X, Down syndrome, and autism: comparison of the emergence of deviant language.

Authors:  V Sudhalter; I L Cohen; W Silverman; E G Wolf-Schein
Journal:  Am J Ment Retard       Date:  1990-01

5.  Association of FMR1 repeat size with ovarian dysfunction.

Authors:  A K Sullivan; M Marcus; M P Epstein; E G Allen; A E Anido; J J Paquin; M Yadav-Shah; S L Sherman
Journal:  Hum Reprod       Date:  2004-12-17       Impact factor: 6.918

6.  Frequency of the fragile X syndrome in infantile autism. A Swedish multicenter study.

Authors:  H K Blomquist; M Bohman; S O Edvinsson; C Gillberg; K H Gustavson; G Holmgren; J Wahlström
Journal:  Clin Genet       Date:  1985-02       Impact factor: 4.438

7.  Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.

Authors:  Y H Fu; D P Kuhl; A Pizzuti; M Pieretti; J S Sutcliffe; S Richards; A J Verkerk; J J Holden; R G Fenwick; S T Warren
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

Review 8.  Fragile X and autism: a multicenter survey.

Authors:  W T Brown; E C Jenkins; I L Cohen; G S Fisch; E G Wolf-Schein; A Gross; L Waterhouse; D Fein; A Mason-Brothers; E Ritvo
Journal:  Am J Med Genet       Date:  1986 Jan-Feb

9.  Absence of expression of the FMR-1 gene in fragile X syndrome.

Authors:  M Pieretti; F P Zhang; Y H Fu; S T Warren; B A Oostra; C T Caskey; D L Nelson
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  Cytogenetic abnormalities and fragile-X syndrome in Autism Spectrum Disorder.

Authors:  Kavita S Reddy
Journal:  BMC Med Genet       Date:  2005-01-18       Impact factor: 2.103

View more
  6 in total

Review 1.  Genetic insights into the functional elements of language.

Authors:  Adam Szalontai; Katalin Csiszar
Journal:  Hum Genet       Date:  2013-06-08       Impact factor: 4.132

Review 2.  Neuropathology and animal models of autism: genetic and environmental factors.

Authors:  Bharathi S Gadad; Laura Hewitson; Keith A Young; Dwight C German
Journal:  Autism Res Treat       Date:  2013-09-16

3.  Towards a Better Molecular Diagnosis of FMR1-Related Disorders-A Multiyear Experience from a Reference Lab.

Authors:  Sylwia Olimpia Rzońca; Monika Gos; Daniel Szopa; Danuta Sielska-Rotblum; Aleksandra Landowska; Agnieszka Szpecht-Potocka; Michał Milewski; Jolanta Czekajska; Anna Abramowicz; Ewa Obersztyn; Dorota Maciejko; Tadeusz Mazurczak; Jerzy Bal
Journal:  Genes (Basel)       Date:  2016-09-02       Impact factor: 4.096

4.  A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder.

Authors:  Laura A Potter; Danielle A Scholze; Hazel Maridith B Biag; Andrea Schneider; Yanjun Chen; Danh V Nguyen; Akash Rajaratnam; Susan M Rivera; Patrick S Dwyer; Flora Tassone; Reem R Al Olaby; Nimrah S Choudhary; Maria J Salcedo-Arellano; Randi J Hagerman
Journal:  Front Psychiatry       Date:  2019-11-06       Impact factor: 4.157

5.  Screening for FMR1 CGG Repeat Expansion in Thai Patients with Autism Spectrum Disorder.

Authors:  Areerat Hnoonual; Charunee Jankittunpaiboon; Pornprot Limprasert
Journal:  Biomed Res Int       Date:  2021-12-08       Impact factor: 3.411

Review 6.  Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models.

Authors:  Polina Kosillo; Helen S Bateup
Journal:  Front Neural Circuits       Date:  2021-07-23       Impact factor: 3.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.